WeedMD’s Starseed Medicinal Announces the Release of Strain-Specific Products for PAX® ERA® Vaporizer

Published: February 26, 2021

WeedMD’s Starseed Medicinal Announces the Release of Strain-Specific Products for PAX® ERA® Vaporizer

WeedMD Inc., a federally licensed producer and distributor of medical-grade cannabis, announced it will commence selling Pedro’s Sweet Sativa, strain-specific PAX® ERA® products to its Starseed Medicinal clients starting March 6th, 2021. The launch of its latest Cannabis 2.0 offering is in partnership with Pax Labs, Inc. (“PAX”), a leader in premium cannabis vaporizer technology, with award-winning devices for both oil concentrates and flower.

The Company’s Starseed Medicinal-branded oil pods in award-winning strain-specific variants, using cannabis-derived terpenes produced in-house, will be available for purchase via its online medical store. WeedMD’s adult-use Color Cannabis-branded PAX ERA pods are expected to be available through supply arrangements with provincial retailers commencing Q2, 2021.

“In keeping with our long-standing tradition of releasing products first to our medical community, we’re thrilled to launch the PAX ERA line-up in our award-winning Pedro’s Sweet Sativa strain as the latest addition to our growing portfolio,” said George Scorsis, Executive Chairman and CEO. “With product features that offer an updated medical experience, our teams worked together over the past few months to finely curate this portfolio of vaporizer products using our premier, quality-produced, strain-specific biomass. We’re looking forward to expanding with additional terpene-rich strains such as Mango Haze and Black Sugar Rose, particularly as our next launch of concentrates will include our adult-use Color Cannabis-branded PAX ERA pods.”

PAX is a market leader with over two million devices sold worldwide and an established reputation as the best-selling pen-and-pod system in the U.S. Its closed-loop PAX ERA pods, for use with PAX’s high-tech oil vaporizers, are dependable, leak-resistant and designed to be clog-free.

WeedMD’s partnership with PAX is expected to further accelerate the growth of the Company’s Cannabis 2.0 product strategy as it continues to expand into new formats using its own indoor and outdoor-cultivated biomass, processed at its state-of-the-art extraction hub in Aylmer, Ontario. WeedMD currently produces terpene-infused 510-thread vape cartridges for its medical-branded Aurum vapes as well as its adult-use brands Color Cannabis and Saturday Cannabis.

Access WeedMD’s 2021 Shareholder Newsletter here. Updated investor presentation and corporate deck can be found here.

WeedMD Inc. is the publicly traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, ON as well as a fully-licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in cannabis extraction.

Recent News

View All News Items

Latest Article

High Spirits and Higher Sales: Cannabis Seen as a Staple During the Holidays

High Spirits and Higher Sales: Cannabis Seen as a Staple During the Holidays

As the holiday season approaches, consumers across Canada are gearing up for festivities and gift-giving. While traditional retail industries have long capitalized on holiday consumer spending habits, the cannabis market is quickly establishing itself as a key player in this annual economic surge.

Read Article